WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

CroíValve adds $20m to Series B, taking round to $36m

The fresh funding brings CroíValve's total raised, including grant financing, to $43m as it accelerates trials for its minimally invasive heart valve device.

Raccontata damorningstar.comsiliconrepublic.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
siliconrepublic.comStai leggendo17 h fa

CroíValve adds $20m to Series B, taking round to $36m

The fresh funding brings CroíValve's total raised, including grant financing, to $43m as it accelerates trials for its minimally invasive heart valve device.

originale
morningstar.com1 g fa

CroíValve Announces Expansion of Series B Financing with $27 Million Additional Capital to Fund DUO Adapt in…

CroíValve Announces Expansion of Series B Financing with $27 Million Additional Capital to Fund DUO Adapt in an Enlarged TANDEM II Study

Leggi questa versione → originale

Timeline cronologica

  1. martedì 23 giugno 2026·morningstar.com

    CroíValve Announces Expansion of Series B Financing with $27 Million Additional Capital to Fund DUO Adapt in an Enlarged TANDEM II Study

    CroíValve Announces Expansion of Series B Financing with $27 Million Additional Capital to Fund DUO Adapt in an Enlarged TANDEM II Study

  2. mercoledì 24 giugno 2026·siliconrepublic.com

    CroíValve adds $20m to Series B, taking round to $36m

    The fresh funding brings CroíValve's total raised, including grant financing, to $43m as it accelerates trials for its minimally invasive heart valve device.